Breast Cancer Research and Treatment View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1981

PUBLISHER

Springer US

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/10549

Recent publications latest 20 shown

  • 2019-04-12 Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
  • 2019-04-12 The association between mammographic density and breast cancer risk in Western Australian Aboriginal women.
  • 2019-04-12 Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review.
  • 2019-04-11 Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy.
  • 2019-04-11 Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).
  • 2019-04-11 Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
  • 2019-04-10 Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
  • 2019-04-10 Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
  • 2019-04-06 Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
  • 2019-04-06 Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women.
  • 2019-04-06 Effects of physical and mind-body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis.
  • 2019-04-05 Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm.
  • 2019-04-04 Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
  • 2019-04-04 GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.
  • 2019-04-02 Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer
  • 2019-04-02 Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
  • 2019-04 Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
  • 2019-04 A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types
  • 2019-04-01 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion
  • 2019-04 The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies
  • Subjects

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.208", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "2.066", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "3.605", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "3.626", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "4.085", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "3.940", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "4.198", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.859", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "4.696", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "4.469", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "4.431", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2008", 
            "ratingValue": "5.684", 
            "type": "Rating"
          }
        ], 
        "description": "

    Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a \"market place\" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

    Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Breast Cancer Research and Treatment aims to fill this need.

    Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.

    ", "editor": [ { "familyName": "Lippman", "givenName": "Marc", "type": "Person" } ], "id": "sg:journal.1092777", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0167-6806", "1573-7217" ], "license": "Hybrid (Open Choice)", "name": "Breast Cancer Research and Treatment", "productId": [ { "name": "scopus_id", "type": "PropertyValue", "value": [ "28766" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0167-6806/BREAST CANCER RESEARCH AND TREATMENT" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "8111104" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "342632" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "10549" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 82002391" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "92777" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "15824" ] } ], "publisher": { "name": "Springer US", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "1981", "type": "Periodical", "url": "http://link.springer.com/journal/10549" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1092777'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1092777'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1092777'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1092777'


     

    This table displays all metadata directly associated to this object as RDF triples.

    146 TRIPLES      21 PREDICATES      41 URIs      36 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1092777 schema:about sg:ontologies/product-market-codes/H33160
    2 schema:contentRating N1cd307edab1249fda21bec9f416935d2
    3 N23720bfaf78044c49a1d4699cfeca06f
    4 N54bd331644b64aaaa23528fd0467016d
    5 N62f19f2585734f2f92f8f049e65d6b7f
    6 N62f897b7a82d4aad9fb5423d78124a69
    7 N6740a1213a4c45dc93e338e29b9a1ea8
    8 N6a9ab5d90f7f420b8ae1ffaf7d3a3273
    9 N887f6ca2446d44299d20a01bfa95264f
    10 Nba94e45a74504cec8267f47815a89b95
    11 Ncff561b3725c49f6b66386840ef937ed
    12 Nd14da340a31f43059a12a162e7495edf
    13 Nf88efd7824d4499e8050378d928646dd
    14 schema:description <p><i>Breast Cancer Research and Treatment</i> provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.<br/><br/>Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. <i>Breast Cancer Research and</i> <i>Treatment</i> aims to fill this need.<br/><br/>Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer. </p>
    15 schema:editor Nc376800cd27040b083b6f36c6536a722
    16 schema:inLanguage en
    17 schema:isAccessibleForFree false
    18 schema:issn 0167-6806
    19 1573-7217
    20 schema:license Hybrid (Open Choice)
    21 schema:name Breast Cancer Research and Treatment
    22 schema:productId N0ee4a6f18ad1403d92ea971360e66f6a
    23 N29bba4b1dae5489c80f282ea3e40766b
    24 N3986a0c8c52a485584bbcaef153579e4
    25 Nabeb1d0c40da455aa5c2fdb43fc1f5dd
    26 Nb01988de94fc4c2292dc4cdf64013695
    27 Nd09b71bc3fd448c99d3e683bec77e107
    28 Nd39fd32422f749bb98ff5f869e6cf6b1
    29 Nf9503982b7e54f2c92e00138c7a64258
    30 schema:publisher N51426c05d52f4dff83ddb7cd7e5a055c
    31 schema:publisherImprint Springer
    32 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777
    33 schema:sdDatePublished 2019-03-18T11:05
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher N7e0f5d89da1c42ec9df2dcc71406016a
    36 schema:startYear 1981
    37 schema:url http://link.springer.com/journal/10549
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset journals
    40 rdf:type schema:Periodical
    41 N0ee4a6f18ad1403d92ea971360e66f6a schema:name dimensions_id
    42 schema:value 92777
    43 rdf:type schema:PropertyValue
    44 N10529593bca34901ba547c33b28d5456 schema:familyName Lippman
    45 schema:givenName Marc
    46 rdf:type schema:Person
    47 N11e07c121c3045d5a71beebae9f1def0 rdf:first snip
    48 rdf:rest rdf:nil
    49 N1cd307edab1249fda21bec9f416935d2 schema:author Nf7daa653bf964504821581c3e1d488e8
    50 schema:dateCreated 2013
    51 schema:ratingValue 4.198
    52 rdf:type schema:Rating
    53 N23720bfaf78044c49a1d4699cfeca06f schema:author Na10fd86791d04f32994128144fffbe99
    54 schema:dateCreated 2016
    55 schema:ratingValue 3.626
    56 rdf:type schema:Rating
    57 N29bba4b1dae5489c80f282ea3e40766b schema:name lccn_id
    58 schema:value sn 82002391
    59 rdf:type schema:PropertyValue
    60 N3986a0c8c52a485584bbcaef153579e4 schema:name nsd_ids_id
    61 schema:value 342632
    62 rdf:type schema:PropertyValue
    63 N3f7652a81903425488b6d5d38dc08388 rdf:first impact_factor_wos
    64 rdf:rest rdf:nil
    65 N47c0645410fe4c1789cb670f9ef24dfb rdf:first impact_factor_wos
    66 rdf:rest rdf:nil
    67 N47dd349390894b999014c4c85e1233bb rdf:first impact_factor_wos
    68 rdf:rest rdf:nil
    69 N51426c05d52f4dff83ddb7cd7e5a055c schema:name Springer US
    70 rdf:type schema:Organization
    71 N521280722c9846caabbfa75f6266540f rdf:first impact_factor_wos
    72 rdf:rest rdf:nil
    73 N54bd331644b64aaaa23528fd0467016d schema:author N47dd349390894b999014c4c85e1233bb
    74 schema:dateCreated 2012
    75 schema:ratingValue 4.469
    76 rdf:type schema:Rating
    77 N62f19f2585734f2f92f8f049e65d6b7f schema:author N7c886bdc47794b32a6cce459b89878e6
    78 schema:dateCreated 2009
    79 schema:ratingValue 4.696
    80 rdf:type schema:Rating
    81 N62f897b7a82d4aad9fb5423d78124a69 schema:author N9ed2cb56339543eaa1df2c7c7e39a2b9
    82 schema:dateCreated 2010
    83 schema:ratingValue 4.859
    84 rdf:type schema:Rating
    85 N6740a1213a4c45dc93e338e29b9a1ea8 schema:author N3f7652a81903425488b6d5d38dc08388
    86 schema:dateCreated 2017
    87 schema:ratingValue 3.605
    88 rdf:type schema:Rating
    89 N6a9ab5d90f7f420b8ae1ffaf7d3a3273 schema:author Ne2f2c224d4344935b2f5c2882041bde0
    90 schema:ratingValue 2.066
    91 rdf:type schema:Rating
    92 N76ed54e85ae84101a1416a61768172ad rdf:first impact_factor_wos
    93 rdf:rest rdf:nil
    94 N7c886bdc47794b32a6cce459b89878e6 rdf:first impact_factor_wos
    95 rdf:rest rdf:nil
    96 N7e0f5d89da1c42ec9df2dcc71406016a schema:name Springer Nature - SN SciGraph project
    97 rdf:type schema:Organization
    98 N7fdef9e452514849a677aacec0389453 rdf:first impact_factor_wos
    99 rdf:rest rdf:nil
    100 N887f6ca2446d44299d20a01bfa95264f schema:author N47c0645410fe4c1789cb670f9ef24dfb
    101 schema:dateCreated 2011
    102 schema:ratingValue 4.431
    103 rdf:type schema:Rating
    104 N9ed2cb56339543eaa1df2c7c7e39a2b9 rdf:first impact_factor_wos
    105 rdf:rest rdf:nil
    106 Na10fd86791d04f32994128144fffbe99 rdf:first impact_factor_wos
    107 rdf:rest rdf:nil
    108 Nabeb1d0c40da455aa5c2fdb43fc1f5dd schema:name springer_id
    109 schema:value 10549
    110 rdf:type schema:PropertyValue
    111 Nb01988de94fc4c2292dc4cdf64013695 schema:name nlm_unique_id
    112 schema:value 8111104
    113 rdf:type schema:PropertyValue
    114 Nba94e45a74504cec8267f47815a89b95 schema:author N521280722c9846caabbfa75f6266540f
    115 schema:dateCreated 2008
    116 schema:ratingValue 5.684
    117 rdf:type schema:Rating
    118 Nc376800cd27040b083b6f36c6536a722 rdf:first N10529593bca34901ba547c33b28d5456
    119 rdf:rest rdf:nil
    120 Ncff561b3725c49f6b66386840ef937ed schema:author N11e07c121c3045d5a71beebae9f1def0
    121 schema:ratingValue 1.208
    122 rdf:type schema:Rating
    123 Nd09b71bc3fd448c99d3e683bec77e107 schema:name scopus_id
    124 schema:value 28766
    125 rdf:type schema:PropertyValue
    126 Nd14da340a31f43059a12a162e7495edf schema:author N76ed54e85ae84101a1416a61768172ad
    127 schema:dateCreated 2015
    128 schema:ratingValue 4.085
    129 rdf:type schema:Rating
    130 Nd39fd32422f749bb98ff5f869e6cf6b1 schema:name wos_id
    131 schema:value 0167-6806/BREAST CANCER RESEARCH AND TREATMENT
    132 rdf:type schema:PropertyValue
    133 Ne2f2c224d4344935b2f5c2882041bde0 rdf:first sjr
    134 rdf:rest rdf:nil
    135 Nf7daa653bf964504821581c3e1d488e8 rdf:first impact_factor_wos
    136 rdf:rest rdf:nil
    137 Nf88efd7824d4499e8050378d928646dd schema:author N7fdef9e452514849a677aacec0389453
    138 schema:dateCreated 2014
    139 schema:ratingValue 3.940
    140 rdf:type schema:Rating
    141 Nf9503982b7e54f2c92e00138c7a64258 schema:name era_ids_id
    142 schema:value 15824
    143 rdf:type schema:PropertyValue
    144 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    145 schema:name Oncology
    146 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...